Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Gastroenterology > Wilson’s Disease Precision Panel

Wilson’s Disease Precision Panel

Wilson disease is a genetic disorder that is associated with an accumulation of copper in the body, excess copper causes many adverse reactions and can be life threatening.
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Wilson disease is a genetic disorder that is associated with an accumulation of copper in the body, excess copper causes many adverse reactions and can be life threatening. Wilson’s disease is caused by changes in the ATP7B gene, changes in this gene can be detected using two different technologies (NGS and MLPA). Wilson’s disease can affect individuals of all ages and is inherited in an autosomal recessive manner.  
  • The Igenomix Wilson Disease Precision Panel can be used to make a directed and accurate differential diagnosis of copper overload, ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

Indication

The Igenomix Wilson Disease Precision Panel is indicated for those patients with a clinical suspicion or diagnosis of Wilson’s Disease presenting with the following manifestations: 

  • Fatigue  
  • Yellow skin (jaundice)  
  • Eye discoloration  
  • Cirrhosis 
  • Chronic active hepatitis 
  • Fulminant hepatic failure 
  • Fluid build-up in the body  
  • Spasms or muscle stiffness  
  • Coordination difficulties  
  • Neuropsychiatric alterations 

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team for early pharmacologic chelation therapy, surgical decompression, and dietary modifications. 
  • Risk assessment of asymptomatic family members according to the mode of inheritance. 

Genes & Diseases

GENE  OMIM DISEASES  INHERITANCE*  % GENE COVERAGE (20X)  HGMD** 
ATP7B  Wilson Disease  AR  99.97%  989 of 1000 

*Inheritance: AD: Autosomal Dominant; AR: Autosomal Recessive; X: X linked; XLR: X linked Recessive; Mi: Mitochondrial; Mu: Multifactorial.  

**Number of clinically relevant mutations according to HGMD 

Methodology

References

See scientific referrals

Członkowska, A., Litwin, T., Dusek, P., Ferenci, P., Lutsenko, S., Medici, V., Rybakowski, J. K., Weiss, K. H., & Schilsky, M. L. (2018). Wilson disease. Nature reviews. Disease primers, 4(1), 21. https://doi.org/10.1038/s41572-018-0018-3 

Bandmann, O., Weiss, K. H., & Kaler, S. G. (2015). Wilson’s disease and other neurological copper disorders. The Lancet. Neurology, 14(1), 103–113. https://doi.org/10.1016/S1474-4422(14)70190-5 

Mulligan C, Bronstein JM. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020 May;38(2):417-432. doi: 10.1016/j.ncl.2020.01.005. Epub 2020 Feb 28. PMID: 32279718. 

BROCHURE

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  +34 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information